Overview of NIFTY®
NIFTY® is a globally renowned non-invasive prenatal test (NIPT) developed exclusively by BGI Genomics. The test requires only a small blood sample (over 5 mL) from the mother. Using advanced low-depth whole-genome sequencing technology and bioinformatics analysis, it evaluates the risk of fetal chromosomal abnormalities. NIFTY® is a safe and highly accurate method for detecting trisomy 21 (T21), trisomy 18 (T18), and trisomy 13 (T13). Additionally, it can screen for other autosomal aneuploidies, sex chromosome aneuploidies, and pathogenic copy number variations (CNVs), providing comprehensive insights into the baby's chromosomal health.
Test Options
Common Autosomal Trisomies
Trisomy 21 (Down syndrome)
Trisomy 18 (Edwards syndrome)
Trisomy 13 (Patau syndrome)
Rare Autosomal Trisomies
Trisomy 9
Trisomy 16
Trisomy 22
Sex Chromosome Aneuploidies*
XO (Turner syndrome)
XXY (Klinefelter syndrome)
XXX (Triple-X syndrome)
XYY (Jacobs syndrome)
Incidental findings*
Other autosomal aneuploidies
Sex Indication*
Y chromosome detection
* The above asterisks are optional detection
The detection of sex chromosomal aneuploidies is limited to singleton pregnancy.
Common Autosomal Trisomies
Trisomy 21 (Down syndrome)
Trisomy 18 (Edwards syndrome)
Trisomy 13 (Patau syndrome)
Rare Autosomal Trisomies
Trisomy 9
Trisomy 16
Trisomy 22
Sex Chromosome Aneuploidies*
XO (Turner syndrome)
XXY (Klinefelter syndrome)
XXX (Triple-X syndrome)
XYY (Jacobs syndrome)
92/10 micro deletion/duplication, including
DiGeorge syndrome (22q11.2 deletion)
1p36 deletion syndrome
Prader-Willi/ Angelman syndrome
Smith-Magenis syndrome
Cri-du-Chat syndrome
4p16.3 deletion syndrome
Distal 18q deletion syndrome
18p deletion syndrome
9p deletion syndrome
Jacobsen Syndrom
Incidental findings*
Other autosomal aneuploidies
& 25Mb CNVs
Sex Indication*
Y chromosome detection
* The above asterisks are optional detection
The detection of sex chromosomal aneuploidies is limited to singleton pregnancy.
Sample Requirements
Sample Type | Quality | Requirements | Shipment |
Maternal peripheral blood | 6-10mL | Using authorised cell-free DNA blood collection tubes | Stored and shipped between 6-35 °C within 4 days. Keep the tubes upright during shipping. |
Plasma | 1.8mL | Plasma separation needs to be completed within 96 hours | Stored and shipped in no higher than -20 °C within 7 days. |
The test is suitable for
Any age of pregnant women from 10 weeks gestation
Singleton, twins and vanishing twin syndrome (VTS) pregnancies
IVF pregnancies
Learn More About Non-invasive Prenatal Test
Why Choose NIPT NIFTY Test
This non-invasive fetal trisomy test provided by BGI Health is the most validated NIPT test for single & multiple pregnancy proved to be 99% accurate on over 250,000 clinical cases and can be used as early as 10th gestational week.
The NIFTY™: Public Education Video
NIFTY™ is a non-invasive prenatal test, which safely screens for certain genetic conditions that might be present in the baby, such as Down syndrome. Find out more about NIFTY™ and listen to expecting parents talk about why they chose to take the test.
Introduction for healthcare providers
A video created for healthcare providers sharing why BGI Genomics' NIFTY test provides comprehensive and thorough screening for expecting mothers.
NIPT provides non-invasive and thorough prenatal screening
The birth of every new life is to be celebrated. Under the guidance of health professionals, our NIPT is suitable for screening advanced pregnancy, twin pregnancy, and pregnancies with a history of trisomy, high risk of aneuploidy, contraindications for invasive procedures, or in-vitro fertilization.
8 Things about Non-invasive prenatal testing
You’ll find answers to key questions, including how to care for yourself during pregnancy to ensure your baby’s health, whether Down syndrome can be detected during pregnancy, what makes NIPT unique, what fetal abnormalities may occur, how accurate NIPT is, who it’s recommended for, whether it’s free, and what steps to take if the results indicate a high risk of chromosomal abnormalities.
Hungarian NIPT Experience - Combining technology with empathy
Anna Kékesi, a molecular biologist from the Istenhegyi Gendiagnostics Center in Hungary shared how non-invasive prenatal testing (NIPT) technology coupled with empathy is supporting the journey of mothers during pregnancy.